Feed/Companies/Callio Therapeutics

Callio Therapeutics

As of 14 Oct 2026, Callio Therapeutics has raised $187M across 1 verified round on record; latest: $187.0 million Series A led by Frazier Life Sciences, announced 3 Mar 2025.

BUILT ON

Visit site

Dual-payload antibody-drug conjugates (ADCs) for cancer treatment.

calliotx.comLinkedInSeattle and Singapore

LATEST ROUND

Series A

$187M · 2025-03-03

RAISED ON RECORD · USD

$187M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series A

$187M · 2025-03-03

[ HISTORY ]

led by Frazier Life Sciences

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$187M	2025-03-03	Frazier Life Sciences	No recent discussion
1 source [ VERIFIED ] read against 1 source

Callio Therapeutics

Rounds

Company

Rounds

Sources

Profile

Investors

Callio Therapeutics

Rounds

Profile

Sources

Series A$187M2025-03-031 source

Investors

Series A$187M2025-03-0310 investors